StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
KRONT.IS$19.45-0.61%
Fair $19.45+0.0%

KRONT.IS

Kron Teknoloji A.S.

Technology / Software - InfrastructureIstanbul

$19.45

-0.12 (-0.61%)

Fairly Valued+0.0%Fair Value $19.45Fund rank 27/100 · Data gapFallback financials|
SA 51/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-7.0M · quality 46.7/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 16/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

51/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · KRONT.ISLocal privado en este navegador · Kron Teknoloji A.S.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.3B

P/E

22.6x

↑

EV/EBITDA

15.1x

↑

ROE

19.8%

↑

Gross Margin

90.3%

↑

Debt/Equity

0.11

↓
52-Week Range$19
$7$25

TradingView lightweight chart

KRONT.IS price, volumen y niveles de valoración

Último $19.45Periodo +11167.6%
Fair value: $19.45

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+23.6%

FCF CAGR

—

FCF margin

-10.2%

FCF / Net income

-0.37x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $536.7M · net income $146.9M · FCF $-54.6M

2022-FY → 2025-FY

Gross margin

90.3%+4.6% pts

Operating margin

28.7%+11.7% pts

Net margin

27.4%+31.0% pts

FCF margin

-10.2%-7.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$536.7M$536.7M$410.5M$445.2M$284.1M
Net Income$146.9M$146.9M$-55.9M$66.9M$-10.2M
EBITDA$218.0M$218.0M$34.3M$128.6M$51.5M
EPS——-0.650.41-0.07
Gross Margin90.3%90.3%85.2%87.4%85.7%
Operating Margin28.7%28.7%-5.4%22.1%17.0%
Net Margin27.4%27.4%-13.6%15.0%-3.6%
Balance Sheet
Debt/Equity0.110.110.230.200.30
Current Ratio1.091.09———
Cash Flow
Free Cash Flow$-54.6M$-54.6M$-7.0M$16.9M$-8.2M
Returns
ROE19.8%19.8%-11.2%14.8%-4.5%
Valuation
P/E22.6222.62—19.18—
EV/EBITDA15.0815.0854.915.3229.20
P/B4.504.503.761.516.56
Growth & Yield
Revenue Growth30.7%30.7%-7.8%56.7%—
EPS Growth——-257.5%734.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +128.8%

Total return

+128.8%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.65 → n/d

Residual

+128.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+128.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.